{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:13:28Z","timestamp":1787321608175,"version":"build-2736575974"},"reference-count":97,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cpcardiol.2026.103395","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:30:35Z","timestamp":1782491435000},"page":"103395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond troponin: emerging biomarker strategies to differentiate type 1 from type 2 myocardial infarction"],"prefix":"10.1016","volume":"51","author":[{"given":"Silvio","family":"Saraullo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0101-4019","authenticated-orcid":false,"given":"Andrea","family":"Palermi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1401-6623","authenticated-orcid":false,"given":"Fabrizio","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda","family":"Furia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1487-9530","authenticated-orcid":false,"given":"Anna Vittoria","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Gallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-8386","authenticated-orcid":false,"given":"Giulia","family":"Renda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2026.103395_bib0001","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/CIRCULATIONAHA.119.042157","article-title":"A proposal for modest revision of the definition of type 1 and type 2 myocardial infarction","volume":"140","author":"De Lemos","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2025.103148","article-title":"Revisiting type 2 myocardial infarction: unmet clinical needs","volume":"50","author":"Palermi","year":"2025","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0003","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/VHRM.S166157","article-title":"Biomarkers in acute myocardial infarction: current perspectives","volume":"15","author":"Aydin","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1017\/S1049023X20000850","article-title":"Diagnostic performance of prehospital point-of-care troponin tests to rule out acute myocardial infarction: a systematic review","volume":"35","author":"Alghamdi","year":"2020","journal-title":"Prehospital Disaster Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.29045\/14784726.2025.9.10.2.17","article-title":"Investigating pre-hospital troponin testing in the diagnosis of acute myocardial infarction: a systematic review","volume":"10","author":"Alexanders","year":"2025","journal-title":"Br Paramed J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0007","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.3390\/jcm14134795","article-title":"The role of c-reactive protein in acute myocardial infarction: unmasking diagnostic, prognostic, and therapeutic insights","volume":"14","author":"Mitsis","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0008","doi-asserted-by":"crossref","first-page":"164","DOI":"10.17305\/bjbms.2012.2470","article-title":"Brain natriuretic peptide release in acute myocardial infarction","volume":"12","author":"Durak-Nalbanti\u0107","year":"2012","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0009","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.3390\/jcm10225278","article-title":"Clinical significance of serum lactate in acute myocardial infarction: a cardiac magnetic resonance imaging study","volume":"10","author":"Park","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0010","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.jacc.2025.09.008","article-title":"Incremental value of cardiac myosin-binding protein c for the early diagnosis of acute myocardial infarction","volume":"86","author":"Lopez-Ayala","year":"2025","journal-title":"JACC"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.039379","article-title":"Comparative analysis of single- and dual-marker strategies for rapid non\u2013st-segment\u2013elevation myocardial infarction rule-out using cardiac myosin-binding protein c, copeptin, and high-sensitivity cardiac troponin t in the emergency department","volume":"14","author":"Yildirim","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0012","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2021.42","article-title":"Type 2 MI and myocardial injury in the era of high-sensitivity troponin","volume":"17","author":"Rafiudeen","year":"2022","journal-title":"Eur Cardiol Rev"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0013","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/eurheartj\/ehaf289","article-title":"Acute coronary syndromes: mechanisms, challenges, and new opportunities","volume":"46","author":"Kraler","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0014","first-page":"343","article-title":"Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the association for acute cardiovascular care and the european society of cardiology working group on thrombosis","volume":"10","author":"Krychtiuk","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/eurheartj\/ehab581","article-title":"Risk factors for type 1 and type 2 myocardial infarction","volume":"43","author":"Wereski","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0016","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11739-021-02920-8","article-title":"Type 2 myocardial infarction: a diagnostic and therapeutic challenge in contemporary cardiology","volume":"17","author":"Merlo","year":"2022","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0017","first-page":"553","article-title":"How is cardiac troponin released from injured myocardium?","volume":"7","author":"Mair","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0018","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/jlpm-23-40","article-title":"Cardiac troponin and the diagnosis of type 2 myocardial infarction and acute non-ischaemic myocardial injury","volume":"9","author":"Taggart","year":"2024","journal-title":"J Lab Precis Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0019","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bja.2023.12.017","article-title":"Pathophysiological mechanisms underlying increased circulating cardiac troponin in noncardiac surgery: a narrative review","volume":"132","author":"Bollen Pinto","year":"2024","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCULATIONAHA.116.023052","article-title":"Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography","volume":"135","author":"Gaggin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0021","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1136\/heartjnl-2021-319118","article-title":"Sex differences in investigations and outcomes among patients with type 2 myocardial infarction","volume":"107","author":"Kimenai","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijcard.2021.05.043","article-title":"Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction","volume":"338","author":"Ariss","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0023","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0024","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.121.054302","article-title":"Cardiac troponin thresholds and kinetics to differentiate myocardial injury and myocardial infarction","volume":"144","author":"Wereski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCULATIONAHA.119.042960","article-title":"High-sensitivity cardiac troponin and the universal definition of myocardial infarction","volume":"141","author":"Chapman","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0026","first-page":"62","article-title":"Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction","volume":"11","author":"Nestelberger","year":"2022","journal-title":"Eu Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276645","article-title":"Diagnostic and prognostic performance of the ratio between high-sensitivity cardiac troponin I and troponin T in patients with chest pain","volume":"17","author":"Eggers","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0028","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.jacc.2023.08.048","article-title":"Cardiac troponin assays to distinguish between acute and chronic myocardial injury","volume":"82","author":"S\u00f6rensen","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0029","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/CIRCULATIONAHA.120.046574","article-title":"Temporal release of high-sensitivity cardiac troponin t and i and copeptin after brief induced coronary artery balloon occlusion in humans","volume":"143","author":"\u00c1rnad\u00f3ttir","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101695","article-title":"Cardiac troponin","volume":"4","author":"McGrath","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0031","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1373\/clinchem.2018.301127","article-title":"Full-size and partially truncated cardiac troponin complexes in the blood of patients with acute myocardial infarction","volume":"65","author":"Vylegzhanina","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117281","article-title":"Fragmentation of human cardiac troponin T after acute myocardial infarction","volume":"542","author":"Katrukha","year":"2023","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0033","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1373\/clinchem.2012.200543","article-title":"Time-dependent degradation pattern of cardiac troponin T following myocardial infarction","volume":"59","author":"Cardinaels","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0034","first-page":"782","article-title":"Novel troponin fragmentation assay to discriminate between Takotsubo syndrome and acute myocardial infarction","volume":"13","author":"Airaksinen","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0035","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/clinchem\/hvae075","article-title":"Highly sensitive immunoassay for long forms of cardiac troponin T using upconversion luminescence","volume":"70","author":"Salonen","year":"2024","journal-title":"Clin Chem"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0036","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/CIRCULATIONAHA.122.060845","article-title":"Novel troponin fragmentation assay to discriminate between troponin elevations in acute myocardial infarction and end-stage renal disease","volume":"146","author":"Airaksinen","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002954","article-title":"Composition of cardiac troponin release differs after marathon running and myocardial infarction","volume":"11","author":"Airaksinen","year":"2024","journal-title":"Open Heart"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0038","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/eurheartj\/ehaf975","article-title":"Long forms of cardiac troponin T for myocardial infarction diagnosis: the SuperTROPO study","volume":"47","author":"Teppo","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0039","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/eurheartj\/ehaf803","article-title":"Long form troponins: a promising new diagnostic tool but not quite ready for prime time","volume":"47","author":"Hamm","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1373\/jalm.2017.025254","article-title":"Proteolytic digestion of serum cardiac troponin I as marker of ischemic severity","volume":"3","author":"Zahran","year":"2018","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0041","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.hrtlng.2024.12.008","article-title":"Biomarker profiles that differentiate type-1 and type 2 myocardial infarction","volume":"70","author":"Mele","year":"2025","journal-title":"Heart Lung"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0042","article-title":"N-terminal pro-b-type natriuretic peptide and b-type natriuretic peptide-to-troponin - ratios for differentiating type 1 from type 2 myocardial infarction: a HIGH-US substudy","volume":"24","author":"Memon","year":"2025","journal-title":"Crit Pathw Cardiol J Evid-Based Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0043","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.ajem.2018.06.073","article-title":"Differentiating type 1 and 2 acute myocardial infarctions using the N-terminal pro B-type natriuretic peptide\/cardiac troponin T ratio","volume":"36","author":"Nowak","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0044","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jamacardio.2021.0669","article-title":"Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction","volume":"6","author":"Nestelberger","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0045","first-page":"963","article-title":"the study group on biomarkers of the ESC association for acute cardiovascular care. Cardiac myosin-binding protein C as a biomarker of acute myocardial infarction","volume":"10","author":"Marber","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0046","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.2147\/IJGM.S476736","article-title":"Importance of H-FABP in early diagnosis of acute myocardial infarction","volume":"17","author":"Pavel","year":"2024","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0047","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/s41467-018-03961-y","article-title":"Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA","volume":"9","author":"Zemmour","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0048","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIRCULATIONAHA.120.046682","article-title":"biomarkers enhance discrimination and prognosis of type 2 myocardial infarction","volume":"142","author":"Horiuchi","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0049","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacc.2013.04.011","article-title":"Copeptin helps in the early detection of patients with acute myocardial infarction","volume":"62","author":"Maisel","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131879","article-title":"Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury","volume":"403","author":"Kassem","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095055","article-title":"Soluble ST2 and Interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome","volume":"9","author":"Demyanets","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0052","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1093\/eurheartj\/ehx457","article-title":"Discrimination of patients with type 2 myocardial infarction","volume":"38","author":"Neumann","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0053","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijcard.2020.01.043","article-title":"Myeloid-related protein 8\/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction","volume":"304","author":"Bormann","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0054","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1186\/s13104-015-1677-8","article-title":"Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease","volume":"8","author":"Fong","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11239-015-1292-5","article-title":"Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction","volume":"42","author":"DeFilippis","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0056","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77413-3","article-title":"Identification of plaque ruptures using a novel discriminative model comprising biomarkers in patients with acute coronary syndrome","volume":"10","author":"Kook","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0057","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jjcc.2010.05.002","article-title":"Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome\u2014comparison with other biomarkers","volume":"56","author":"Kume","year":"2010","journal-title":"J Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001774","article-title":"Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population","volume":"3","author":"Garvin","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0059","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1538-7836.2010.04162.x","article-title":"Thrombin generation in patients with a first acute myocardial infarction","volume":"9","author":"Smid","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0060","first-page":"1","article-title":"Prothrombin fragments in cardiovascular Disease","volume":"51","year":"2010"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0061","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.90.1.61","article-title":"Persistent activation of coagulation mechanism in unstable angina and myocardial infarction","volume":"90","author":"Merlini","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0062","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cca.2006.03.005","article-title":"Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes","volume":"371","author":"Van Der Putten","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0063","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0167-5273(98)00256-3","article-title":"Prothrombin fragments F1+2, thrombin\u2013antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis","volume":"68","author":"Giannitsis","year":"1999","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0064","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1076029607309176","article-title":"Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis","volume":"14","author":"Ota","year":"2008","journal-title":"Clin Appl Thromb"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0065","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1253\/circj.71.1857","article-title":"Association between circulating level of cd40 ligand and angiographic morphologic features indicating high-burden thrombus formation in patients with acute myocardial infarction undergoing primary coronary intervention","volume":"71","author":"Youssef","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0066","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/clinchem\/42.9.1537","article-title":"Thrombus precursor protein (TpP): marker of thrombosis early in the pathogenesis of myocardial infarction","volume":"42","author":"Carville","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0067","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.jacc.2008.01.069","article-title":"Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes","volume":"51","author":"Mega","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0068","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clinbiochem.2022.02.003","article-title":"Diagnostic performance and predictive value of D-dimer testing in patients referred to the emergency department for suspected myocardial infarction","volume":"104","author":"Koch","year":"2022","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0069","first-page":"64","article-title":"Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study","volume":"4","author":"Rutten","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ahj.2003.07.015","article-title":"Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st\u2013segment elevation myocardial infarction","volume":"147","author":"Gy\u00f6ngy\u00f6si","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0071","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9149(97)00945-4","article-title":"Serial changes in plasma levels of soluble p-selectin in patients with acute myocardial infarction","volume":"81","author":"Shimomura","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0072","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cca.2010.12.016","article-title":"Low soluble P-selectin may facilitate early exclusion of acute myocardial infarction","volume":"412","author":"Body","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0073","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/cells9010231","article-title":"Neutrophil extracellular traps and cardiovascular diseases: an update","volume":"9","author":"Bonaventura","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0074","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12950-023-00344-z","article-title":"Neutrophil extracellular traps in acute coronary syndrome","volume":"20","author":"Wu","year":"2023","journal-title":"J Inflamm"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0075","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/biomedicines10081850","article-title":"Neutrophils and neutrophil extracellular traps in cardiovascular disease: an overview and potential therapeutic approaches","volume":"10","author":"Shirakawa","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101193","article-title":"Neutrophil extracellular traps in st-segment elevation myocardial infarction","volume":"3","author":"Kindberg","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0077","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jprot.2017.03.014","article-title":"Systems characterization of differential plasma metabolome perturbations following thrombotic and non-thrombotic myocardial infarction","volume":"160","author":"Trainor","year":"2017","journal-title":"J Proteomics"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0078","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175591","article-title":"Identification of a plasma metabolomic signature of thrombotic myocardial infarction that is distinct from non-thrombotic myocardial infarction and stable coronary artery disease","volume":"12","author":"DeFilippis","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117745","article-title":"Pseudo-targeted metabolic profile differences between emergency patients with type 1 and type 2 myocardial infarction diagnosed by optical coherence tomography","volume":"554","author":"Wang","year":"2024","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0080","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2025-003867","article-title":"Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review","volume":"13","author":"Gouda","year":"2026","journal-title":"Open Heart"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0081","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jacc.2021.06.027","article-title":"A biomarker model to distinguish types of myocardial infarction and injury","volume":"78","author":"Neumann","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0082","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.amjmed.2017.05.049","article-title":"Type 1 and 2 myocardial infarction and myocardial injury: clinical transition to high-sensitivity cardiac troponin I","volume":"130","author":"Sandoval","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0083","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.amjmed.2015.11.035","article-title":"Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction","volume":"129","author":"Baron","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0084","article-title":"Clinical and prognostic implications of high-sensitivity cardiac troponin T concentrations in type 2 non-ST elevation myocardial infarction","volume":"39","author":"Eggers","year":"2022","journal-title":"IJC Heart Vasc"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s12877-025-06169-0","article-title":"NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients","volume":"25","author":"Ma","year":"2025","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0086","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2147\/CIA.S438541","article-title":"Characteristics and prognosis of Type 2 myocardial infarction through worsening renal function and NT-proBNP in older adults with pneumonia","volume":"19","author":"Ma","year":"2024","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0087","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2147\/CIA.S416372","article-title":"Prediction of outcomes through cystatin c and ctni in elderly type 2 myocardial infarction patients","volume":"18","author":"Ma","year":"2023","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0088","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.1503","article-title":"Prognostic role of inflammatory status in type 2 myocardial infarction","volume":"45","author":"Sara Amicone","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0089","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12265-024-10584-w","article-title":"Diagnostic value and short-term prognosis assessment of copeptin in non-st-elevation acute coronary syndrome","volume":"18","author":"Cui","year":"2025","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2025.106694","article-title":"Growth differentiation factor-15 in patients presenting with acute chest pain: diagnostic and prognostic utility","author":"Crisanti","year":"2026","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0091","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2872607","article-title":"Prognostic role of elevated myeloperoxidase in patients with acute coronary syndrome: a systemic review and meta-analysis","volume":"2019","author":"Kolodziej","year":"2019","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0092","article-title":"Correlation analysis of plasma myeloperoxidase level with global registry of acute coronary events score and prognosis in patients with acute non-st-segment elevation myocardial infarction","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0093","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.jacc.2019.02.046","article-title":"Galectin-3 levels and outcomes after myocardial infarction","volume":"73","author":"Asleh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0094","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1730173","article-title":"Galectin-3 in acute myocardial infarction: from molecular mechanisms to clinical translation","volume":"12","author":"Liu","year":"2025","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118584","article-title":"Nucleic acid liquid biopsies in cardiovascular disease: cell-free RNA liquid biopsies in cardiovascular disease","volume":"398","author":"Sharma","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0096","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajem.2025.08.019","article-title":"Differentiating Type 1 and Type 2 myocardial infarction using a machine learning algorithm and biomarkers","volume":"98","author":"Snavely","year":"2025","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cpcardiol.2026.103395_bib0097","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2026.0477","article-title":"Early rule out of myocardial infarction with a novel high-sensitivity cardiac troponin t assay","author":"Thurston","year":"2026","journal-title":"JAMA Cardiol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:13:22Z","timestamp":1787318002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280626001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":97,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0146280626001374"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103395","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond troponin: emerging biomarker strategies to differentiate type 1 from type 2 myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103395"}}